Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
1.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Protein Networks02:26

Protein Networks

3.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adropin and Irisin as Potential Patentable Biomarkers in Metabolic-Associated Fatty Liver Disease: Current Evidence and Future Directions.

Recent patents on biotechnology·2026
Same author

Reusability of immobilised lipase in the production of omega-3 oils from squid viscera.

Applied microbiology and biotechnology·2026
Same author

Phenolic Characterization and Comparative Antioxidant Profiling of Australian <i>Asparagopsis armata</i> and <i>A. taxiformis</i> Across Their Developmental Stages.

Antioxidants (Basel, Switzerland)·2026
Same author

Harnessing Liquid-like Self-Lubricated Silicone Interfaces To Catalyze the Breakdown of Biodegradable Plastics.

ACS applied materials & interfaces·2026
Same author

Engineering frog-skin-inspired wrinkled self-lubricative liquid-like interfaces on biodegradable plastics.

Journal of colloid and interface science·2026
Same author

Ecological Characteristics and Nutritional Values of Australia-Native Brown Algae Species.

Marine drugs·2025

Related Experiment Video

Updated: May 2, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

120

Current protein-based anti-angiogenic therapeutics.

Sanjukta Chakrabarti, Colin J Barrow, Rupinder K Kanwar

  • 1Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine (SoM), Molecular and Medical Research (MMR) Strategic Research Centre, School of Medicine, Faculty of Health, Deakin University, Waurn Ponds Campus, Geelong, Victoria, Australia 3216. jagat.kanwar@deakin.edu.au.

Mini Reviews in Medicinal Chemistry
|February 21, 2014
PubMed
Summary

Angiogenesis, the formation of new blood vessels, is crucial for development but abnormal in disease. Protein-based therapies offer targeted anti-angiogenic treatments with fewer side effects than gene-based options.

More Related Videos

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

9.2K
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

741

Related Experiment Videos

Last Updated: May 2, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

120
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

9.2K
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

741

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Pathology

Background:

  • Angiogenesis is a complex process involving cellular interactions and pathways, essential for normal development but implicated in various diseases when dysregulated.
  • Vascular Endothelial Growth Factor (VEGF) and its receptors are key regulators of angiogenesis.
  • Aberrant angiogenesis leads to pathological conditions, necessitating therapeutic interventions.

Purpose of the Study:

  • To provide a comprehensive overview of angiogenesis.
  • To review current protein-based anti-angiogenic therapeutics.
  • To highlight the advantages of protein-based therapies in research and clinical settings.

Main Methods:

  • Literature review of angiogenesis mechanisms.
  • Analysis of anti-angiogenic therapeutic strategies, including gene-based and protein-based approaches.
  • Comparison of therapeutic modalities based on efficacy, specificity, and adverse effects.

Main Results:

  • Angiogenesis involves intricate molecular signaling pathways, with VEGF playing a central role.
  • Anti-angiogenic therapies target key components of the angiogenic process.
  • Protein-based therapeutics demonstrate advantages in specificity, tolerability, and reduced adverse effects compared to gene-based and small molecule drugs.

Conclusions:

  • Protein-based anti-angiogenic therapies represent a promising avenue for treating diseases associated with abnormal angiogenesis.
  • Further research and clinical trials are essential to fully realize the potential of these therapeutics.
  • Targeting angiogenesis with protein-based drugs offers a potentially safer and more effective treatment strategy.